Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT03133793
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with HFpEF within a 6-month period
* New York Heart Association (NYHA) Classification II-III HF
* Have left ventricular ejection fraction (EF) ≥ 50% documented by an echocardiogram
* Have a telephone or reliable phone contact
* Have their own means of transportation to the study site
Exclusion Criteria:
* Acute coronary syndrome in the past 12 weeks
* Significant valvular heart disease
* Severe cardiac fibrosis (galectin-3 level \> 26 ng/ml)
* Constrictive pericardium
* Pulmonary fibrosis
* Congenital heart disease
* Hypertrophic or infiltrative cardiomyopathy
* Heart transplant
* Left ventricular assist device
* Heart failure (HF) associated hospital admission or emergency room visit within past 30 days
* Recent percutaneous coronary intervention
* Significant renal and/or hepatic dysfunction
* Severe cognitive impairment
* Consumption of any CoQ10 (ubiquinol) or D-ribose supplements
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT03133793
Study Brief:
Protocol Section:
NCT03133793